Case Study: HeliosX Launches Generic GLP-1s in 48 Hours with Conveo

HeliosX launches generic GLP-1s in 48 hours with Conveo

HeliosX, a digital health group behind brands like MedExpress and Dermatica, faced a challenge where traditional qualitative research was too slow for its fast-paced business needs. Stakeholders would cancel research requests due to timelines of a month or more, leaving the team to guess at messaging for sensitive topics like weight loss without crucial consumer insights. To solve this, they turned to Conveo and its AI research assistant to conduct automated video interviews.

Using Conveo, HeliosX could field 80-100 interviews instead of the typical 8-10 and analyze the data in minutes by asking the platform questions. This allowed them to repurpose a single study multiple times. When a generic GLP-1 medication launched with only 48 hours' notice, HeliosX mined this existing Conveo data to instantly find the trusted consumer language needed for their launch, successfully avoiding terms like "cheap" in favor of "more affordable." The solution enabled faster, deeper insights that reached more of the company and transformed how they onboard new staff.

HeliosX